U.S. Beverage Stock News

Advanced Energy Industries (AEIS) has drawn investor attention after being named Investor’s Business Daily’s Stock of the Day, following a technical breakout linked to its AI focused data center and Thailand manufacturing expansion story. See our latest analysis for Advanced Energy Industries. That breakout sits on top of strong recent momentum, with a 90 day share price return of 31.32% and a 1 year total shareholder return of 83.94%, while the latest close is US$229.70. Taken together, this...

At CES 2026, Maplebear (CART), which operates as Instacart, introduced Data Hub, a clean room tool that lets consumer brands combine their own data with Instacart grocery purchase signals. See our latest analysis for Maplebear. The Data Hub launch comes as Maplebear trades at US$44.42 per share, with a 90 day share price return of 12.03% and a 1 year total shareholder return of 3.52%. This suggests recent momentum has been building rather than fading. If this kind of data focused story has...

Tuya (NYSE:TUYA) has begun a shareholder-authorized share repurchase program, allowing buybacks of up to 60,972,194 shares, or 10% of issued capital, aimed at supporting net assets and earnings per share. See our latest analysis for Tuya. Tuya’s latest share repurchase plan comes after a mixed pattern in its share price, with a 7 day share price return of 5.14% but a 90 day share price return of 12.79%. At the same time, the 1 year total shareholder return of 40.65% points to stronger longer...

T1 Energy (TE) recently moved to comply with the One Big Beautiful Bill Act by cutting foreign ownership tied to Trina Solar, revising its certificate of incorporation, and preserving access to key clean energy tax credits. See our latest analysis for T1 Energy. T1 Energy’s recent compliance moves come after a sharp run, with a 90 day share price return of 161.09% and a 30 day gain of 31.22%, even though the year to date share price return is slightly negative and the 3 year total shareholder...

Recent discussion around West Pharmaceutical Services (WST) has centered on declining adjusted operating margins and slower revenue growth versus healthcare peers, as rising competition and higher expenses pressure profitability and leave investors more cautious about the current valuation. See our latest analysis for West Pharmaceutical Services. Those margin concerns are landing at a time when the share price has moved only modestly, with a 90 day share price return of 4.81% and a 1 year...

Kenvue (KVUE) has been drawing investor interest after recent share price moves, with the stock closing at $16.75. That puts the consumer health company’s performance under closer scrutiny against its fundamentals. See our latest analysis for Kenvue. The recent pullback, including a 1 day share price return of 0.42% and a 7 day share price return of 3.35%, comes against a 1 year total shareholder return of 17.13%. This suggests that recent momentum has been fading after earlier weakness. If...

Why Sarepta Therapeutics is on investors’ radar today Sarepta Therapeutics (SRPT) has drawn fresh attention after recent trading left the stock at a last close of $22.35, reflecting mixed short term returns and weaker performance over the past year and the past 3 months. See our latest analysis for Sarepta Therapeutics. For Sarepta, the recent 6.08% 1-day share price return and 3.86% 7-day share price return sit against a much weaker backdrop, with a 1-year total shareholder return decline of...

If you are wondering whether USA Rare Earth is priced fairly or whether the recent buzz has left value on the table, this article walks through what the numbers say about the stock. At a last close of US$17.52, USA Rare Earth has posted returns of 44.4% over the past week, 1.7% over the last month, 23.8% year to date, and 31.0% over the past year. These moves raise questions about how sentiment lines up with underlying value. Recent attention around USA Rare Earth has been driven by ongoing...

If you are wondering whether Blue Owl Capital's current share price offers good value, you are not alone. This article will focus squarely on what the numbers say about that question. The stock last closed at US$16.04, with returns of 7.0% over the past week, a 1.2% decline over the last 30 days, 4.8% year to date, a 25.9% decline over 1 year, 57.5% over 3 years and 74.4% over 5 years. Those mixed returns have kept Blue Owl on many investors' watchlists, especially as alternative asset...

Coterra Energy (CTRA) is back on watch as Chief Financial Officer Shane Young appears at the Goldman Sachs Energy, CleanTech & Utilities Conference, drawing fresh attention to the company’s income profile and exposure to natural gas prices. See our latest analysis for Coterra Energy. The conference appearance comes after a softer patch for the stock, with a 1 month share price return of an 8.47% decline and a 7 day share price return of a 5.61% decline. However, the 3 month share price return...

Mizuho Securities’ defense of Credo Technology Group Holding (CRDO) after a sharp share-price drop, combined with strong revenue growth figures and upbeat analyst commentary, has put the stock firmly back on many investors’ watchlists. See our latest analysis for Credo Technology Group Holding. The recent selloff comes after a strong multi year run, with a very large 3 year total shareholder return and a 76.61% total shareholder return over the last year. At the same time, the 30 day share...

Leggett & Platt (LEG) has drawn fresh attention after a recent share price move, with the stock up 5.3% over the past day and 6.4% over the past week. See our latest analysis for Leggett & Platt. The recent 1-day share price return of 5.34% and 7-day return of 6.40% sit against a 90-day share price return of 30.79% and a 1-year total shareholder return of 20.93%. However, the 3 and 5-year total shareholder returns remain deeply negative, so recent momentum contrasts with a weaker long-term...

Nike’s leadership has recently stepped up insider buying, with CEO Elliott Hill investing over US$1,000,000 and director Tim Cook acquiring 50,000 shares, underscoring internal confidence amid a multi-quarter reset shaped by tariffs, China weakness, and pressure at Converse. At the same time, Nike has exited its RTFKT NFT venture and is reconsidering its Converse portfolio, signaling a sharper focus on core sports performance products and wholesale partnerships as it works through revenue...

If you have ever wondered whether Exxon Mobil's share price is really offering fair value today, you are not alone. This article is built to help you size that up clearly. The stock last closed at US$121.05, with returns of 0.0% over 7 days, 3.9% over 30 days, a 1.3% decline year to date, and 15.4% over the last year, with a very large 5 year return that sits a long way above 500%. Recent market interest in Exxon Mobil has been shaped by ongoing conversations about large integrated energy...

In its latest reported quarter, e.l.f. Beauty posted 14.2% year-on-year revenue growth but missed analyst estimates and issued full-year guidance below expectations, disappointing the market. This setback comes even as the company expands its brand presence, including integrating its billion-dollar Rhode acquisition and continuing to gain shelf space and consumer attention. We’ll now explore how this weaker-than-expected guidance, despite ongoing brand expansion, reshapes e.l.f. Beauty’s...

Recent share performance and what it might signal Paramount Skydance (PSKY) has drawn fresh attention after recent trading, with the stock closing at US$12.50 and showing negative returns over the past week, month, past 3 months, and year to date. See our latest analysis for Paramount Skydance. That recent 3 month share price return of 30.44% and 30 day share price return of 14.21% decline come after a 1 year total shareholder return of 18.75%, so short term momentum looks weaker than the...

If you are wondering whether GE Vernova’s share price still reflects fair value after a strong run, you are not alone. The stock recently closed at US$686.33, with returns of 4.0% over the last 7 days, 8.7% over 30 days, 1.0% year to date, and 86.7% over the past year. This naturally raises questions about what is already priced in. Recent coverage around GE Vernova has focused on its position as a pure play in capital goods following its separation from the wider GE group. This has put a...

If you are wondering whether Novavax at US$7.44 is a bargain or a value trap, this article will help you size up what the current price might be implying about the stock. Over the short term, the stock has seen returns of 10.7% over the last week and 9.7% over the last month. Year to date it is at 4.3%. The 1 year return sits at a 22.5% decline, with a 37.3% decline over 3 years and a 94.1% decline over 5 years. Recent news around Novavax has focused on its position in the vaccine market and...

Stryker recently announced it will report its fourth-quarter and full-year 2025 results on January 29, 2026, alongside a webcast discussion of the figures. This update comes as Stryker’s medical technologies reach over 150 million patients annually and analysts highlight its multi-year track record of organic revenue and earnings growth. We’ll now examine how Raymond James’s upgrade, grounded in Stryker’s consistent organic growth and market share gains, could influence its investment...

If you are wondering whether Vericel's current share price lines up with its underlying worth, this article walks through the numbers in a clear, structured way. Vericel recently closed at US$39.34, with returns of 9.2% over 7 days, 5.5% over 30 days, 10.5% year to date, a 33.9% decline over 1 year, 42.4% over 3 years and 6.6% over 5 years. Taken together, these figures provide a mix of shorter term momentum and longer term context. That performance sits against a backdrop of ongoing...

In recent days, BWS Financial elevated Innodata to a top pick for 2026 and highlighted its first government contract, a US$25,000,000 engagement that could support its role in building sovereign AI systems. The upgrade emphasizes Innodata’s shift from a pure data provider toward a higher-value AI consulting and integration partner for major technology and government clients. We’ll now explore how the new government contract influences Innodata’s existing investment narrative around...

If you are wondering whether Cboe Global Markets is fairly priced or not, its recent share performance and current valuation metrics make it a stock many investors are taking a closer look at. The share price recently closed at US$250.09, with returns of 0.8% year to date and 31.1% over the past year, in addition to a very large 5 year gain that works out to roughly 2.8x. Recent news coverage has focused on Cboe's role as a major global exchange operator and its position in options,...

What recent performance tells you about Molina Healthcare Molina Healthcare (MOH) has quietly shifted in recent weeks, with the stock showing a 1 day return of 1.06% and an 8.24% move over the past week, drawing fresh attention from investors. Over the past month, the share price return of 21.64% contrasts with an 8.96% decline over the past 3 months. This pattern can prompt investors to reassess both recent momentum and longer term positioning. See our latest analysis for Molina...

In late 2025, NextEra Energy entered an equity distribution agreement to sell up to US$4.00 billion of common stock through an at-the-market follow-on offering, while reaffirming long-term targets for at least 8% annual adjusted EPS growth through 2032 and high single- to low double-digit dividend growth through 2028. The company’s decision to raise fresh equity capital while reiterating ambitious earnings and dividend goals highlights management’s commitment to funding large-scale grid and...